Table 2.
Mean (SD) lipid levels on steady state fluvastatin and rosuvastatin treatment, and percent change from steady state fluvastatin treatment to one month of treatment with 20 mg rosuvastatin per day in renal transplant recipients.
| Lipid parameter | On fluvastatin treatment | On rosuvastatin treatment | % Change | P-value |
|---|---|---|---|---|
| LDL-cholesterol | ||||
| mmol/L | 3.54 (0.93) | 2.45 (0.72) | -30.2 (12.2) | < 0.01 |
| mg/dL | 137 (36.0) | 94.6 (27.6) | ||
| Total cholesterol | ||||
| mmol/L | 5.98 (1.05) | 4.82 (0.81) | -18.2 (9.59) | < 0.01 |
| mg/dL | 231 (40.7) | 187 (31.3) | ||
| HDL-cholesterol | ||||
| mmol/L | 1.63 (0.42) | 1.71 (0.48) | 5.38 (10.4) | 0.14 |
| mg/dL | 62.7 (16.4) | 65.9 (18.5) | ||
| Triglycerides | ||||
| mmol/L | 2.38 (1.04) | 1.85 (0.71) | -18.2 (17.7) | 0.01 |
| mg/dL | 210 (91.9) | 164 (63.0) |
LDL, low-density lipoprotein; HDL, high-density lipoprotein.